Difficulty: Medium
Average Score: 64%
Simulated
During interleukin drug therapy, a client is showing signs of severe fluid retention, with increasing dyspnea and severe peripheral edema. The next dose of the interleukin is due now. Which action will the nurse take next?
Correct answer
B
Rationale
Correct Answer: B. Hold the drug, and notify the prescriber.
Rationale: Severe fluid retention, dyspnea, and peripheral edema are signs of a serious adverse reaction to interleukin therapy. Holding the drug is crucial to prevent further harm to the client. Notifying the prescriber promptly allows for immediate assessment and appropriate intervention. Continuing the drug or administering other medications without consulting the prescriber could exacerbate the client's condition. Monitoring alone is insufficient when the client is experiencing severe symptoms requiring immediate action.
Rationale: Severe fluid retention, dyspnea, and peripheral edema are signs of a serious adverse reaction to interleukin therapy. Holding the drug is crucial to prevent further harm to the client. Notifying the prescriber promptly allows for immediate assessment and appropriate intervention. Continuing the drug or administering other medications without consulting the prescriber could exacerbate the client's condition. Monitoring alone is insufficient when the client is experiencing severe symptoms requiring immediate action.